Immune cell therapy takes aim at muscle weakness disease
Disease control
Recruiting now
This early-stage study tests a new treatment called anito-cel for people with generalized myasthenia gravis, a condition causing muscle weakness. Anito-cel is a type of CAR-T cell therapy that targets specific immune cells to reduce disease activity. The study will enroll about 3…
Phase: PHASE1 • Sponsor: Arcellx, Inc. • Aim: Disease control
Last updated May 15, 2026 11:55 UTC